A recent study conducted by researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering has shed light on the role of antibodies in fighting herpes simplex virus (HSV) infections.
These findings, published in Cell Reports Medicine on February 12, 2024, could pave the way for new treatments or vaccines for neonatal herpes.
In their experiments, the research team used a neonatal mouse model to mimic human neonatal infections, engineering antibodies with different properties to explore how they mediate protection.
Read More
